Cue Biopharma Inc (NAS:CUE)
$ 1.01 -0.03 (-2.88%) Market Cap: 63.98 Mil Enterprise Value: 41.08 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 61/100

Q4 2023 Cue Biopharma Inc Earnings Call Transcript

Apr 08, 2024 / 08:30PM GMT
Release Date Price: $2.04 (+10.27%)
Operator

Greetings, and welcome to the Cue Biopharma Investor Update Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Dan Passeri, Cue Biopharma's Chief Executive Officer. You may begin.

Daniel Passeri
Cue Biopharma Inc - Chief Executive Officer, Director

Thank you, and good afternoon, everyone. As a reminder, this presentation and discussion is being recorded and will be available on our website for the next 30 days. Also, please be aware that the slides accompanying today's update may be advanced directly by those listening in on the call and will notify you on what slide we're on throughout this presentation. Joining me on today's call are Dr. Anish Suri, our President and Chief Scientific Officer; Dr. Matteo Levisetti, our Chief Medical Officer; and Kerri-Ann Millar, our Chief Financial Officer.

As shown on slide 2, our presentation and overview may contain some forward-looking statements and any forward-looking statement made during this call represents the company's views only

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot